Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 404

1.

Hospital admissions caused by adverse drug events: an Australian prospective study.

Phillips AL, Nigro O, Macolino KA, Scarborough KC, Doecke CJ, Angley MT, Shakib S.

Aust Health Rev. 2014 Feb;38(1):51-7. doi: 10.1071/AH12027.

PMID:
24351707
2.

Incidence, preventability, and impact of Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study.

Kunac DL, Kennedy J, Austin N, Reith D.

Paediatr Drugs. 2009;11(2):153-60. doi: 10.2165/00148581-200911020-00005.

PMID:
19301935
3.

Identifying hospital admissions due to adverse drug events using a computer-based monitor.

Jha AK, Kuperman GJ, Rittenberg E, Teich JM, Bates DW.

Pharmacoepidemiol Drug Saf. 2001 Mar-Apr;10(2):113-9.

PMID:
11499849
4.

Risk factors for hospital admissions associated with adverse drug events.

Kongkaew C, Hann M, Mandal J, Williams SD, Metcalfe D, Noyce PR, Ashcroft DM.

Pharmacotherapy. 2013 Aug;33(8):827-37. doi: 10.1002/phar.1287. Epub 2013 May 17.

PMID:
23686895
5.

Evaluating iatrogenic prescribing: development of an oncology-focused trigger tool.

Hébert G, Netzer F, Ferrua M, Ducreux M, Lemare F, Minvielle E.

Eur J Cancer. 2015 Feb;51(3):427-35. doi: 10.1016/j.ejca.2014.12.002. Epub 2014 Dec 27.

PMID:
25549531
6.

Drug-related visits to the medical emergency department: a prospective study from India.

Malhotra S, Jain S, Pandhi P.

Int J Clin Pharmacol Ther. 2001 Jan;39(1):12-8.

PMID:
11204932
7.

The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group.

Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA, Small SD, Sweitzer BJ, Leape LL.

JAMA. 1997 Jan 22-29;277(4):307-11.

PMID:
9002493
8.

Suspected adverse drug events requiring emergency department visits or hospital admissions.

Raschetti R, Morgutti M, Menniti-Ippolito F, Belisari A, Rossignoli A, Longhini P, La Guidara C.

Eur J Clin Pharmacol. 1999 Feb;54(12):959-63.

PMID:
10192758
9.

Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital.

Carnevali L, Krug B, Amant F, Van Pee D, Gérard V, de Béthune X, Spinewine A.

Ann Pharmacother. 2013 Nov;47(11):1414-9. doi: 10.1177/1060028013500939.

PMID:
24285758
10.

Implementing a clinical pharmacy survey of adverse drug events in a French emergency department.

Roulet L, Asseray N, Dary M, Chiffoleau A, Potel G, Ballereau F.

Int J Clin Pharm. 2012 Dec;34(6):902-10. doi: 10.1007/s11096-012-9691-6. Epub 2012 Aug 25.

PMID:
22923368
11.

Adverse drug events in surgical patients: an observational multicentre study.

de Boer M, Boeker EB, Ramrattan MA, Kiewiet JJ, Dijkgraaf MG, Boermeester MA, Lie-A-Huen L.

Int J Clin Pharm. 2013 Oct;35(5):744-52. doi: 10.1007/s11096-013-9797-5. Epub 2013 May 31.

PMID:
23722455
12.

Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients.

Hamilton H, Gallagher P, Ryan C, Byrne S, O'Mahony D.

Arch Intern Med. 2011 Jun 13;171(11):1013-9. doi: 10.1001/archinternmed.2011.215.

PMID:
21670370
13.

Emergency department visits caused by adverse drug events: results of a French survey.

Queneau P, Bannwarth B, Carpentier F, Guliana JM, Bouget J, Trombert B, Leverve X, Lapostolle F, Borron SW, Adnet F; Association Pédagogique Nationale pour l'Enseignement de la Thérapeutique (APNET)..

Drug Saf. 2007;30(1):81-8.

PMID:
17194173
14.

Practical approach to determining costs and frequency of adverse drug events in a health care network.

Senst BL, Achusim LE, Genest RP, Cosentino LA, Ford CC, Little JA, Raybon SJ, Bates DW.

Am J Health Syst Pharm. 2001 Jun 15;58(12):1126-32.

PMID:
11449856
15.

Adverse drug events as a cause of hospital admission in the elderly.

Chan M, Nicklason F, Vial JH.

Intern Med J. 2001 May-Jun;31(4):199-205.

PMID:
11456032
16.

[Usefulness of MBDS in detection of adverse drug events].

Sánchez Muñoz LA, Castiella Herrero J, Sanjuán Portugal FJ, Naya Manchado J, Alfaro Alfaro MJ.

An Med Interna. 2007 Mar;24(3):113-9. Spanish.

PMID:
17590131
17.

Computerized surveillance of adverse drug events in hospital patients.

Classen DC, Pestotnik SL, Evans RS, Burke JP.

JAMA. 1991 Nov 27;266(20):2847-51. Erratum in: JAMA 1992 Apr 8;267(14):1922.

PMID:
1942452
18.

Adverse drug event nonrecognition in emergency departments: an exploratory study on factors related to patients and drugs.

Roulet L, Ballereau F, Hardouin JB, Chiffoleau A, Potel G, Asseray N.

J Emerg Med. 2014 Jun;46(6):857-64. doi: 10.1016/j.jemermed.2013.11.124. Epub 2014 Feb 22.

PMID:
24565882
19.

[Detecting adverse drug events during the hospital stay].

Berga Culleré C, Gorgas Torner MQ, Altimiras Ruiz J, Tuset Creus M, Besalduch Martín M, Capdevila Sunyer M, Torres Gubert M, Casajoana Cortinas MT, Baró Sabaté E, Fernández Solà JR, Moron i Besolí A, Odena Estradé E, Serrais Benavente J, Vitales Farrero MT, Codina Jané C.

Farm Hosp. 2009 Nov-Dec;33(6):312-23. Spanish.

PMID:
20038390
20.

Adverse drug events identified by triggers at a teaching hospital in Brazil.

Giordani F, Rozenfeld S, Martins M.

BMC Pharmacol Toxicol. 2014 Dec 13;15:71. doi: 10.1186/2050-6511-15-71.

Supplemental Content

Support Center